SB

Sagamore Bioventures

North America, California, United States, San Diego

Description

Sagamore Bioventures provides later stage venture investments and is based in the United States.

Investor Profile

Sagamore Bioventures has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series E, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Singapore.
  • Strong thematic focus on Medical, Health Care, Medical Device.

Stage Focus

  • Series C (33%)
  • Series E (17%)
  • Series D (17%)
  • Series B (17%)
  • Series A (17%)

Country Focus

  • United States (67%)
  • Singapore (33%)

Industry Focus

  • Medical
  • Health Care
  • Medical Device
  • Service Industry
  • Wellness
  • Biotechnology
  • Pharmaceutical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sagamore Bioventures frequently co-invest with?

3i Group
Europe, England, United Kingdom, London
Co-Investments: 3
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 2
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 3
CB Health Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 3
POSCO BioVentures
North America, California, United States, Carlsbad
Co-Investments: 3
Tudor Investments
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Sherbrooke Capital
North America, Massachusetts, United States, Newton
Co-Investments: 3
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 3

What are some of recent deals done by Sagamore Bioventures?

ASLAN Pharmaceuticals

Singapore, Central Region, Singapore

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series CDec 7, 2015
Amount Raised: $34,000,000
ASLAN Pharmaceuticals

Singapore, Central Region, Singapore

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series BOct 10, 2013
Amount Raised: $22,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series EMar 30, 2010
Amount Raised: $36,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series DApr 13, 2007
Amount Raised: $25,500,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series CMar 14, 2006
Amount Raised: $29,750,000
Presidio Pharmaceuticals

San Francisco, California, United States

Presidio Pharmaceuticals discovers, develops and commercializes novel therapeutics for viral infections, including HCV and HIV.

BiotechnologyMedicalPharmaceutical
Series AMar 1, 2006